NKT cells are not critical for HSV-1 disease resolution

被引:37
作者
Cornish, AL
Keating, R
Kyparissoudis, K
Smyth, MJ
Carbone, FR
Godfrey, DI [1 ]
机构
[1] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia
[2] Peter MacCallum Canc Ctr, Canc Immunol Program, Trescowthick Labs, Melbourne, Vic, Australia
关键词
CD1d; HSV-1; infection; NKT cell; T cell;
D O I
10.1111/j.1440-1711.2005.01396.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
NKT cells are a minor subset of T cells that have important roles in controlling immune responses in disease states including cancer, autoimmunity and pathogenic infections. In contrast to conventional T cells, NKT cells express an invariant TCR and respond to glycolipids presented by CD1d. In this study, we sought to investigate the role of NKT cells in regulating the response to infection with HSV-1, and the mechanism involved, in well-established mouse models. Previous studies of HSV-1 disease in mice have shown clear roles for CD4(+) and CD8(+) T cells. The role of NKT cells in the resolution of HSV-1 (KOS strain) infection was investigated through flank zosteriform or footpad infection in wild-type versus CD1d-deficient mice, by measurement of viral plaque-forming units at different sites after infection, lesion severity and HSV-1-specific T-cell responses. In contrast to a previous study using a more virulent strain of HSV-1 (SC16 strain), no differences were observed in disease magnitude or resolution, and furthermore, the T-cell response to HSV-1 (KOS strain) was unaltered in the absence of NKT cells. In conclusion, this study shows that NKT cells do not play a general role in controlling the resolution or severity of HSV-1 infection. Instead, the resolution or severity of the infection may depend on the HSV-1 strain under investigation.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 50 条
[1]   Plasmodium berghei infection in mice induces liver injury by an IL-12-and toll-like receptor/myeloid differentiation factor 88-dependent mechanism [J].
Adachi, K ;
Tsutsui, H ;
Kashiwamura, S ;
Seki, E ;
Nakano, H ;
Takeuchi, O ;
Takeda, K ;
Okumura, K ;
Van Kaer, L ;
Okamura, H ;
Akira, S ;
Nakanishi, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5928-5934
[2]   Expression of intracellular IFN-γ in HSV-1-specific CD8+ T cells identifies distinct responding subpopulations during the primary response to infection [J].
Andersen, H ;
Dempsey, D ;
Chervenak, R ;
Jennings, SR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2101-2107
[3]   EPITOPE SPECIFICITY OF H-2K(B)-RESTRICTED, HSV-1-CROSS-REACTIVE, AND HSV-2-CROSS-REACTIVE CYTOTOXIC T-LYMPHOCYTE CLONES [J].
BONNEAU, RH ;
SALVUCCI, LA ;
JOHNSON, DC ;
TEVETHIA, SS .
VIROLOGY, 1993, 195 (01) :62-70
[4]   MODULATION OF ACUTE AND LATENT HERPES-SIMPLEX VIRUS-INFECTION IN C57BL/6 MICE BY ADOPTIVE TRANSFER OF IMMUNE LYMPHOCYTES WITH CYTOLYTIC ACTIVITY [J].
BONNEAU, RH ;
JENNINGS, SR .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1480-1484
[5]   Mechanism of CD1d-restricted natural killer T cell activation during microbial infection [J].
Brigl, M ;
Bry, L ;
Kent, SC ;
Gumperz, JE ;
Brenner, MB .
NATURE IMMUNOLOGY, 2003, 4 (12) :1230-1237
[6]   PREVENTION OF RECURRENT HERPES-SIMPLEX VIRUS (HSV) INFECTIONS IN HIV-INFECTED PERSONS [J].
CHANG, E ;
ABSAR, N ;
BEALL, G .
AIDS PATIENT CARE, 1995, 9 (05) :252-255
[7]   Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1 [J].
Coles, RM ;
Mueller, SN ;
Heath, WR ;
Carbone, FR ;
Brooks, AG .
JOURNAL OF IMMUNOLOGY, 2002, 168 (02) :834-838
[8]   Antigen-specific CD8(+) T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection [J].
Cose, SC ;
Jones, CM ;
Wallace, ME ;
Heath, WR ;
Carbone, FR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) :2310-2316
[9]   CHARACTERIZATION OF A DIVERSE PRIMARY HERPES-SIMPLEX VIRUS TYPE-1 GB-SPECIFIC CYTOTOXIC T-CELL RESPONSE SHOWING A PREFERENTIAL V-BETA BIAS [J].
COSE, SC ;
KELLY, JM ;
CARBONE, FR .
JOURNAL OF VIROLOGY, 1995, 69 (09) :5849-5852
[10]   Treatment with α-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive [J].
Duthie, MS ;
Kahn, SJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5778-5785